Both type I and type III interferons are required to restrict measles virus growth in lung epithelial cells

被引:10
作者
Taniguchi, Midori [1 ]
Yanagi, Yusuke [1 ]
Ohno, Shinji [2 ]
机构
[1] Kyushu Univ, Dept Virol, Fac Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
[2] Univ Ryukyus, Grad Sch Med, Dept Virol, 207 Uehara, Nakagami, Okinawa 9030215, Japan
基金
日本学术振兴会;
关键词
WILD-TYPE; RIG-I; ANTIVIRAL PROTECTION; V PROTEIN; RECEPTOR; INFECTION; VACCINE; EXPRESSION; MACAQUES; STRAINS;
D O I
10.1007/s00705-018-4087-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Measles virus (MeV) first infects immune cells in the respiratory tract of a human host, spreads to lymphoid organs throughout the body, and finally enters and grows in respiratory epithelial cells before being released and transmitted to the next host. Thus, efficient growth in respiratory epithelial cells is important for the person-to-person transmission of MeV. Upon viral entry, host cells detect viral nucleic acids and produce interferons (IFNs) to control viral growth. Type I (IFN-/) and type III (IFN-) IFNs have largely common induction and signaling mechanisms and stimulate expression of similar target genes but utilize distinct receptors. To determine the relative contributions of type I and type III IFNs to the control of MeV growth in epithelial cells, we examined the growth of MeV and that of its mutants lacking either type I or type III IFN receptor in the human lung epithelial cell line H358. Our results revealed that both type I and type III IFNs are required to restrict MeV growth in H358 cells and that the induction of type III as well as type I IFNs was increased in the absence of the MeV nonstructural V protein.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 44 条
[1]   Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract [J].
Andreakos, Evangelos ;
Salagianni, Maria ;
Galani, Ioanna E. ;
Koltsida, Ourania .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[2]   The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines [J].
Berghall, Heidi ;
Siren, Jukka ;
Sarkar, Devanand ;
Julkunen, Ilkka ;
Fisher, Paul B. ;
Vainionpaa, Raija ;
Matikainen, Sampsa .
MICROBES AND INFECTION, 2006, 8 (08) :2138-2144
[3]  
BROWER M, 1986, CANCER RES, V46, P798
[4]   mda-5, but not RIG-I, is a common target for paramyxovirus V proteins [J].
Childs, Kay ;
Stock, Nicola ;
Ross, Craig ;
Andrejeva, Jelena ;
Hilton, Louise ;
Skinner, Michael ;
Randall, Richard ;
Goodbourn, Stephen .
VIROLOGY, 2007, 359 (01) :190-200
[5]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[6]   Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies [J].
Coughlin, Melissa M. ;
Beck, Andrew S. ;
Bankamp, Bettina ;
Rota, Paul A. .
VIRUSES-BASEL, 2017, 9 (01)
[7]   MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN Induction [J].
Cuevas, Rolando A. ;
Ghosh, Arundhati ;
Wallerath, Christina ;
Hornung, Veit ;
Coyne, Carolyn B. ;
Sarkar, Saumendra N. .
JOURNAL OF IMMUNOLOGY, 2016, 196 (09) :3877-3886
[8]   Antagonism of the Phosphatase PP1 by the Measles Virus V Protein Is Required for Innate Immune Escape of MDA5 [J].
Davis, Meredith E. ;
Wang, May K. ;
Rennick, Linda J. ;
Full, Florian ;
Gableske, Sebastian ;
Mesman, Annelies W. ;
Gringhuis, Sonja I. ;
Geijtenbeek, Teunis B. H. ;
Duprex, W. Paul ;
Gack, Michaela U. .
CELL HOST & MICROBE, 2014, 16 (01) :19-30
[9]   Nectin-4-Dependent Measles Virus Spread to the Cynomolgus Monkey Tracheal Epithelium: Role of Infected Immune Cells Infiltrating the Lamina Propria [J].
Frenzke, Marie ;
Sawatsky, Bevan ;
Wong, Xiao X. ;
Delpeut, Sebastien ;
Mateo, Mathieu ;
Cattaneo, Roberto ;
von Messling, Veronika .
JOURNAL OF VIROLOGY, 2013, 87 (05) :2526-2534
[10]   Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness [J].
Galani, Ioanna E. ;
Triantafyllia, Vasiliki ;
Eleminiadou, Evridiki-Evangelia ;
Koltsida, Ourania ;
Stavropoulos, Athanasios ;
Manioudaki, Maria ;
Thanos, Dimitris ;
Doyle, Sean E. ;
Kotenko, Sergei V. ;
Thanopoulou, Kalliopi ;
Andreakos, Evangelos .
IMMUNITY, 2017, 46 (05) :875-+